IW 397

September 2, 2026 Viktor Zarev 0 min read
  1. Medical groups support flu and Covid shots amid confusion.
  2. Congo Ebola outbreak deaths pass 3k, no slowdown in sight.
  3. UnitedHealthcare cuts prior authorization from 1,700 codes.
  4. HCA cuts corporate and support roles following earnings hit.
  5. Scan.com raises $220M for U.S. medical imaging network.
  6. Self-pay hospital visits spike as coverage losses mount.
  7. Employers begin cutting GLP-1 weight-loss coverage.
  8. DaVita agrees to $15M settlement for data breach claims.
  9. McKesson confirms data theft from third-party app cyberattack.
  10. Florida sues PBMs over alleged price fixing.
Get twice-weekly insights on the biggest stories shaping cardiology.

You might also like

Cardiogenetics September 10, 2026

Can Polygenic Risk Scores Uncover Hidden CVD? September 10, 2026

It’s rare that one gene causes CVD, just as it’s rare for one CV condition to occur in isolation. In a recent JACC issue, researchers show that […]

Cardiology Pharmaceuticals September 10, 2026

Novo, Novartis, and How Two Trials Cast Doubt on CVD Biomarkers September 10, 2026

Cardiology just took back-to-back blows to two of its most promising prevention strategies. One drug for lowering lipoprotein(a) and another targeting interleukin-6 both failed in major trials, even as fresh data reaffirms just how much those factors matter.

Surgeries & Interventions September 3, 2026

A Tale of Two Studies and the Importance of Patient Selection September 3, 2026

Two recent studies are forcing an important conversation in cardiology – some of the field's most common procedures may not be as clearly beneficial as open-label data originally suggests.